These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 9306429
1. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts. Gridley DS, Archambeau JO, Andres MA, Mao XW, Wright K, Slater JM. Oncol Res; 1997; 9(5):217-27. PubMed ID: 9306429 [Abstract] [Full Text] [Related]
2. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor. Gridley DS, Li J, Kajioka EH, Andres ML, Moyers MF, Slater JM. Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248 [Abstract] [Full Text] [Related]
3. Evaluation of TNF-alpha effects on radiation efficacy in a human lung adenocarcinoma model. Gridley DS, Andres ML, Garner C, Mao XW, Slater JM. Oncol Res; 1996; 8(12):485-95. PubMed ID: 9160352 [Abstract] [Full Text] [Related]
4. Evaluation of pGL1-TNF-alpha therapy in combination with radiation. Li J, Andres ML, Fodor I, Nelson GA, Gridley DS. Oncol Res; 1998; 10(7):379-87. PubMed ID: 10063972 [Abstract] [Full Text] [Related]
5. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Staba MJ, Mauceri HJ, Kufe DW, Hallahan DE, Weichselbaum RR. Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548 [Abstract] [Full Text] [Related]
6. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model. Gridley DS, Baer JR, Cao JD, Miller GM, Kim DW, Timiryasova TM, Fodor I, Slater JM. Int J Oncol; 2002 Aug; 21(2):251-9. PubMed ID: 12118318 [Abstract] [Full Text] [Related]
7. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ. Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107 [Abstract] [Full Text] [Related]
9. Immunohistological analysis of immune cell infiltration of a human colon tumor xenograft after treatment with Stealth liposome-encapsulated tumor necrosis factor-alpha and radiation. Kim DW, Andres ML, Miller GM, Cao JD, Green LM, Seynhaeve AL, Ten Hagen TL, Gridley DS. Int J Oncol; 2002 Nov; 21(5):973-9. PubMed ID: 12370743 [Abstract] [Full Text] [Related]
10. Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation. Mao XW, Green LM, Gridley DS. Oncology; 2001 Nov; 61(3):243-53. PubMed ID: 11574781 [Abstract] [Full Text] [Related]
11. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model. Slagel DE, Feola J, Houchens DP, Ovejera AA. Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979 [Abstract] [Full Text] [Related]
12. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J. Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708 [Abstract] [Full Text] [Related]
13. A model using radiation and plasmid-mediated tumor necrosis factor-alpha gene therapy for treatment of glioblastomas. Baher AG, Andres ML, Folz-Holbeck J, Cao JD, Gridley DS. Anticancer Res; 1999 Sep; 19(4B):2917-24. PubMed ID: 10652573 [Abstract] [Full Text] [Related]
14. Modulation of innate immunological factors by STEALTH liposome-encapsulated tumor necrosis factor-alpha in a colon tumor xenograft model. Kim DW, Andres ML, Kajioka EH, Dutta-Roy R, Miller GM, Seynhaeve AL, ten Hagen TL, Gridley DS. Anticancer Res; 2002 Sep; 22(2A):777-88. PubMed ID: 12014650 [Abstract] [Full Text] [Related]
15. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice. Phillips PC, Levow C, Catterall M, Colvin OM, Pastan I, Brem H. Cancer Res; 1994 Feb 15; 54(4):1008-15. PubMed ID: 8313355 [Abstract] [Full Text] [Related]
16. [Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta]. Enomoto H, Yoshida J, Kageyama N, Ueda R, Kato T, Ota K. Gan To Kagaku Ryoho; 1986 May 15; 13(5):1953-61. PubMed ID: 3085596 [Abstract] [Full Text] [Related]
17. Evaluation of TNF-alpha/Bax gene therapy and radiation against C6 glioma xenografts. Gridley DS, Timiryasova TM, Miller GM, Andres ML, Dutta-Roy R, Bayeta EJ, Fodor I. Technol Cancer Res Treat; 2003 Feb 15; 2(1):41-50. PubMed ID: 12625753 [Abstract] [Full Text] [Related]
18. [Antitumor effect of intra-arterial tumor necrosis factor-alpha in rats with transplanted intracerebral glioma and its evaluation by MRI]. Harada K, Yoshida J, Wakabayashi T, Sugita K, Kurisu K, Uozumi T, Zieroth BF, Takahashi M, Yamanaka T. No Shinkei Geka; 1995 Dec 15; 23(12):1069-74. PubMed ID: 8927213 [Abstract] [Full Text] [Related]
19. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Pollack IF, Erff M, Ashkenazi A. Clin Cancer Res; 2001 May 15; 7(5):1362-9. PubMed ID: 11350907 [Abstract] [Full Text] [Related]
20. NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts. Papadopoulou MV, Bloomer WD, Hollingshead MG. Anticancer Res; 2005 May 15; 25(3B):1865-9. PubMed ID: 16158918 [Abstract] [Full Text] [Related] Page: [Next] [New Search]